Neuro Kinetics to Showcase Enhanced Control & Analysis Software at Otolaryngology Conference
PITTSBURGH, Sept. 22 /PRNewswire/ -- Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com), manufacturers of noninvasive medical diagnostic equipment used worldwide to test for vestibular and neurological conditions, said today that it will demonstrate its recently enhanced VEST™ control and analysis software at the upcoming annual meeting of the American Academy of Otolaryngology in Boston (http://am2010.entnet.org/).
NKI will be demonstrating the software on its I-Portal® VNG (Video Nystagmography) system at booth #873.
Otolaryngologists and other clinical specialists use NKI's VEST software to conduct various vestibular, ocular-motor and optokinetic tests that assess balance and central and peripheral neurologic functions.
NKI recently released version 6.8 of the VEST software package. The enhanced software improves the accuracy and breadth of various tests that may be performed on NKI's medical devices, including the dynamic unilateral centrifugation test, various nystagmus detection tests and smooth pursuit analysis. VEST 6.8 also adds new ease of use and improves data management options.
NKI also said that it will focus on expiring tax advantages currently available to clinicians considering a purchase of capital equipment, such as NKI's medical devices. For the remainder of 2010, clinicians can deduct 100% of new business property up to an annual ceiling amount. Next year, the percentage of capital expenditures that can be deducted is likely to be reduced significantly.
"With our ongoing quality enhancements to our devices and software, coupled with the very real and dramatic tax benefits to purchasing in 2010, we think otolaryngologists and others should act now," said J. Howison Schroeder, NKI president and CEO. "We are excited to be exhibiting at the AAO conference in Boston as it will give us the opportunit